 Hexamethonium midazolam terminate dysrhythmias hypertension intracerebroventricular bupivacaine rabbits Previous studies bupivacaine central nervous system CNS capable signs bupivacaine cardiovascular toxicity mechanisms bupivacaine CNS cardiovascular toxicity groups halothane-anesthetized rabbits infusion intracerebroventricular icv bupivacaine intravenous iv phenylephrine dysrhythmias hypertension group icv bupivacaine micrograms mean SEM dysrhythmias min icv saline dysrhythmias hypertension group icv bupivacaine-induced hypertension dysrhythmias icv midazolam min dysrhythmias hypertension min hexamethonium iv dysrhythmias hypertension group icv bupivacaine-induced dysrhythmias hypertension inspired halothane concentration group iv phenylephrine-induced dysrhythmias hypertension icv midazolam results icv bupivacaine dysrhythmias hypertension nervous system ANS brain stem finding peripheral autonomic blockade hexamethonium dysrhythmias hypertension supports mechanism icv bupivacaine increase autonomic outflow blockade inhibitory gamma-aminobutyric acid GABA neurons principal tonic inhibitors ANS